Two Federal Grants Support Quintessence Biosciences, Inc.

Madison, Wis. - Quintessence Biosciences has announced the receipt of two federal grants from the National Cancer Institute to advance its EVade cancer-fighting technology products into in-vivo testing.
MORE ON THIS TOPIC